| Literature DB >> 35366117 |
Yuxiang Xue1, Chenchen Liu2, Gavin Andrews3, Jinyan Wang4, Yi Ge5.
Abstract
In the last decade, carbon quantum dots (CQDs), as a novel class of carbon-based nanomaterials, have received increasing attention due to their distinct properties. CQDs are ultimately small nanoparticles with an average size below 10 nm, possessing high water solubility, alluring photoluminescence, photostability, excellent biocompatibility, low/none toxicity, environmental friendliness, and high sustainability, etc. In history, there are intermittent threats from viruses to humans, animals and plants worldwide, resulting in enormous crises and impacts on our life, environment, economy and society. Some recent studies have unveiled that certain types of CQDs exhibited high and potent antiviral activities against various viruses such as human coronavirus, arterivirus, norovirus and herpesvirus. Moreover, they have been successfully explored and developed for different virus detections including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This article exclusively overviews and discusses the recent progress of designing, synthesizing, modifying/functionalizing and developing CQDs towards effective virus detection as well as the inhibition and treatment of viral infection. Their mechanisms and applications against various pathogenic viruses are addressed. The latest outcomes for combating the coronavirus disease 2019 (COVID-19) utilizing CQDs are also highlighted. It can be envisaged that CQDs could further benefit the development of virus detectors and antiviral agents with added broad-spectrum activity and cost-effective production.Entities:
Keywords: Antiviral agent; COVID-19; Carbon dot; Carbon quantum dot; Nanomaterial; SARS-CoV-2; Virus detection
Year: 2022 PMID: 35366117 PMCID: PMC8976173 DOI: 10.1186/s40580-022-00307-9
Source DB: PubMed Journal: Nano Converg ISSN: 2196-5404
Some major life-threatening viruses and examples of their main treatment and diagnostic methods
| Types of virus | Caused disease | Example of treatment method | Example of diagnostic method | Refs. |
|---|---|---|---|---|
| Variola virus | Smallpox | Vaccines and antiviral agents/drugs (e.g | Immune serum complement fixation test; physical exam of skin | [ |
| HIV | Acquired immunodeficiency syndrome (AIDS) | Antiretroviral agents/drugs (e.g. NRTIs and NNRTIs) HIV protease inhibitors (e.g. mozenavir) HIV vaccines (e.g. neutralizing antibodies and recombinant viral vectors) | PCR or viral load test; P24 test; ELISA; rapid finger prick and oral swab test; Western blot test | [ |
| SARS | Severe acute respiratory syndrome (SARS) | Antiviral agents/drugs (e.g | Serology; real time reverse transcription PCR; ELISA | [ |
| MERS | Middle east respiratory syndrome (MERS) | Antiviral agents/drugs (e.g. type 1 IFN, IFN-α2b combined with ribavirin, chloroquine, and lopinavir); convalescent sera from recovered patients | Serology; real time reverse transcription PCR; ELISA; Immunofluorescence assay | [ |
| Ebola | Ebola hemorrhagic fever | Monoclonal antibodies (e.g. REGN-EB3, mAb114, and ZMapp); antiviral agents/drugs (e.g | Quantitative reverse transcription PCR; ELISA antigen capture; Ebola-specific IgM and IgG antibody detection | [ |
| SARS-CoV-2 | Coronavirus disease 2019 (COVID-19) | Vaccines (e.g. inactivated vaccines, mRNA vaccines, recombinant protein vaccines, and live attenuated vaccines); antiviral agents/drugs (e.g. umifenovir; lopinavir, ritonavir, tocilizumab, and sarilumab) | Real time reverse transcription PCR by using nasal swab or sputum sample; blood and antibody test | [ |
Fig. 1Schematic representation of synthesizing carbon quantum dots for the detection, prevention/inhibition, and treatment of pathogenic viruses
Fig. 2General entry routes of viruses [27]. Reproduced with permission.
Copyright © 2017, Elsevier B.V
Various nanoparticles used for viral detection
| Type of nanoparticle | Application | Principle | Refs. |
|---|---|---|---|
| AuNPs | Detection of human papillomavirus in cervical carcinoma | AuNPs were coupled with silver straining for signal amplification | [ |
| Detection of surface antigen of HBV in biological sample | AuNPs were surface labelled with a monoclonal HBV surface antibody and the technique was validated by ELISA | [ | |
| Detection of HCV RNA | Using size- and distance-dependent nanoparticle surface-energy transfer technique. When RNA bound to AuNPs, the color of solution was changed from red to yellow | [ | |
| Detection of HVA Vall7 polyprotein gene, HVB surface antigen gene, HIV, Ebola virus, variola virus (smallpox), and Bacillus anthracis (BA) protective antigen gene | AuNPs were probes labeled with oligonucleotides and Raman-active dyes to achieve surface-enhanced Raman scattering | [ | |
Detection of SARS Detection of SARS-CoV-2 | Mainly through colorimetry (pp1ab gene detection) and electrochemical methods (nucleocapsid protein gene detection) for rapid and specific molecular detection A colorimetric assay where the thiol-modified antisense oligonucleotides-capped AuNPs accumulated selectively in the presence of its target RNA sequence in SARS-CoV-2 and showed the plasmon resonance change on the surface | [ [ | |
| Detection of Hantaan virus nucleocapsid protein | Using functionalized AuNPs to enhance the ultrasensitive immuno-PCR assay based on bio-barcode assay technique | [ | |
| Detection of Ebola virus | Using a luminescence assay consisting of BaGdF5:Yb/Er up-conversion nanoparticles conjugated with oligonucleotide probe and AuNPs linked with target Ebola virus oligonucleotide | [ | |
| AgNPs | Detection of single influenza viruses | Using the inherent electrochemical activity of virus surface modified by AgNPs in the solution to detect virus at low concentration quantitatively | [ |
| Early detection of COVID-19 | Redox probes containing the silver ions (Ag+) in the hexathia-18-crown-6 (HT18C6) were used for voltametric determination of RdRP of SARS-CoV-2 virus | [ | |
| AlNPs | Detection of dengue virus | A small and thin piece of nano-porous alumina membrane was used to detect virus using electrochemical impedance spectroscopy | [ |
| Iron oxide NPs | Detection of hepatitis A virus (HAV) | Using protamine-coated iron oxide (Fe3O4) magnetic nanoparticles to concentrate HAV for further detection | [ |
| Detection of hepatitis B virus (HBV) | Using gold-coated iron oxide nanoparticle as the HBV DNA probe | [ | |
| Magnetic NPs | Detection of infuenza A virus H5N1 | Aniline monomer polymerized around gamma iron (III) oxide (γ-Fe2O3) cores were served as the basis of a direct-charge transfer biosensor to detect surface glycoprotein hemagglutinin of influenza A virus | [ |
| Detection of hepatitis B virus (HBV) | Amino functionalized carbon coated magnetic nanoparticles were used for electrochemical detection of hybridization of nucleic acid of HBV | [ | |
| CNTs | Detection of HIV-1 | Using NiCo2O4/CoO@CNTs which have high electrochemical activity, good biocompatibility, and strong bio-affinity toward the probe DNA | [ |
| Detection of SARS-CoV-2 | Target SARS-CoV-2 viral RNA was captured by ssDNA-nanotube constructs via hybridization and separated from the liquid phase in a single-tube system with minimal chemical reagents, for downstream quantitative reverse transcription PCR detection | [ | |
| SiNPs | Detection of HIV-1 Detection of Hepatitis B virus (HBV) | Using Streptavidin-labelled and Europium-doped fluorescent SiNPs for HIV-1 p24 antigen detection Using Fe3O4/SiO2 nanoparticles to isolate genomic DNA of HBV for HBV detection based on PCR | [ [ |
| Polymeric NPs | Detection of airborne respiratory viruses | TMB-NPs@PLGA-based colorimetric sensor was conjugated to antibodies and bound to the captured virus in the microtiter wells | [ |
| Graphenes | Detection of HIV | Amine-functionalized graphene was conjugated with anti-p24 of HIV to detect various HIV biomarkers via various UV–Vis and Raman spectroscopies | [ |
Various nanoparticles which have been applied as antiviral agents
| Type of nanoparticle | Application | Principle | Refs. |
|---|---|---|---|
| Iron oxide NPs | Inactivation of influenza | Using iron oxide nanozymes to catalyze lipid peroxidation of the viral lipid envelope to inactivate enveloped viruses | [ |
| Inactivation of SARS-CoV-2 | IONPs (e.g. Fe2O3 and Fe3O4) could interact with the spike protein receptor binding domain (S1-RBD) of SARS-CoV-2 that is required for virus attachment to the host cell receptors | [ | |
| ZnO-NPs | Inhibition of H1N1 influenza virus | PEGylated ZnO-NPs could inhibit H1N1 influenza by blocking viral entry | [ |
| AuNPs | Inhibition of HIV infection | AuNPs were coated with multiple copies of an amphiphilic sulfate-ended ligand which could bind the HIV gp120 | [ |
| Ag NPs | Inhibition of growth of H3N2 influenza virus | AgNPs could interact with H3N2 influenza virus and lead to the destruction of morphologic viral structures | [ |
| Inhibition of HIV replication | Blocking of viral entry and having an interference with viral membrane fusion in a short period of time | [ | |
| Inhibition of H1N1 influenza A virus | AgNPs were combined with chitosan to inhibit viral penetration into the host cell by direct binding with viral envelope glycoproteins | [ | |
| Inhibition of herpes simplex virus type 1 (HSV-1) | AgNPs were capped with mercaptoethane sulfonate (Ag-MES) inhibiting HSV-1 to have the interaction between viral envelope glycoproteins and cell surface heparan sulfate | [ | |
| Inhibition of hepatitis B virus replication | AgNPs which have good binding affinity for HBV DNA inhibited the in vitro production of HBV RNA and extracellular virion | [ | |
| Hybrid nanocomposites | Inhibition of enveloped virus | GO sheets were combined with AgNPs to inhibit the infection of viruses with low cytotoxicity to cells | [ |
| Inhibition of herpes simplex virus type 1 (HSV-1) | Sulfonated magnetic nanoparticles were functionalized with reduced graphene oxide showing a photothermal antiviral activity | [ |
Fig. 3The major milestones in the development of carbon-based nanomaterials [85]. Reproduced with permission.
Copyright © 2020 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Fig. 4A schematic representation of general synthetic approaches of carbon quantum dots [112]. Reproduced with permission.
Copyright © 2022 Wiley‐VCH GmbH
Comparison of some recently reported synthetic CQDs
| Approach | Carbon source | Synthetic method | Quantum yield (%) | Application | Refs. |
|---|---|---|---|---|---|
| Top-down | Carbon nano powder | Acidic oxidation | N/A | Drug delivery | [ |
| Top-down | Graphite flakes | laser ablation | 9.1 | N/A | [ |
| Top-down | Graphite rod | Electrochemical exfoliation, acidic oxidation | 15.5 | Bioimaging | [ |
| Top-down | Graphite | Arc discharge | N/A | Emitting materials | [ |
| Top-down | Graphite powder | Acidic oxidation | 14 | N/A | [ |
| Bottom-up | Citric acid | Hydrothermal | 51 | Alcohol sensors | [ |
| Bottom-up | Glycyrrhizic acid | Hydrothermal | 1.41 | Anti-virus | [ |
| Bottom-up | L-cysteine and citric acid | Microwave irradiation | 54 | Glutathione detection | [ |
| Bottom-up | Gallic acid | Microwave irradiation | 25 | Bioimaging, Anti-tumor | [ |
| Bottom-up | Oligomer polyamide resin | Ultrasonic treatment | 28.3 | Photoluminescent ink | [ |
| Bottom-up | Toluene | Laser irradiation | 13.5 | N/A | [ |
| Bottom-up | o-phenylenediamine | Electrochemical method | 71 | Bioimaging | [ |
Fig. 5Top images are photographs of CQDs samples A–D in aqueous solution under daylight (left) and UV light (right). The bottom four graphs show their absorption curves and their PL emission spectra under excitation with light of different wavelengths [146]. Reproduced with permission.
Copyright © 2016, American Chemical Society
Fig. 6A Antibody conjugation to CQDs via covalent chemistry. B Antibody conjugation to MP-MoO3 QDs via covalent chemistry. C Magnetic separation and purification step upon target virus addition. D Core-satellite immunocomplex of CQDs and MP-MoO3 QDs in the presence of influenza virus [177]. Reproduced with permission.
Copyright © 2020 Elsevier B.V
Fig. 7Schematic representation of the construction of detection probe (A) and detection principle of GQDs-based nano system (B) [184]. Reproduced with permission.
Copyright © 2013 Elsevier B.V
Fig. 8p24 Intensity of HIV-1 viral post-infection to MOLT-4 cells in the presence of pure CQDs (orange bars), boronic acid modified CDs (green bars), and boronic acid modified CQDs + Duviral (21 mg, purple bars). All of the data is presented as mean ± SD [193]. Reproduced with permission.
Copyright © 2020, American Chemical Society
Fig. 9A Representative photographs of mice on day 7 post-infection (a) without and (b) treated with Cur-CQDs-180 (25 mg kg−1). The red arrow indicates apparent limb paralysis in the untreated infected mice. B survival rates, C clinical scores, and D body weights of (i) newborn mice without infection and (ii−iv) newborn mice intraperitoneally injected with (ii) PBS, (iii) curcumin (25 mg kg−1), or (iv) Cur-CQDs-180 (25 mg kg−1) followed by intraperitoneal injection of EV71 at the dose of 2 × 106 PFU. A group of uninfected mice treated with sterile PBS was used as an uninfected control. The curcumin or Cur-CQDs-180 treatment was performed every 12 h daily for seven consecutive days. The mice were monitored for 15 d [202]. Reproduced with permission.
Copyright © 2019 WILEY‐VCH Verlag GmbH & Co. KGaA
Fig. 10A TEM image of OVA-CQDs complex. B Percentage of positive BMDC cells after incubating with OVA and OVA conjugated CDs. C ELISA result of IgG concentration in sera of BALB/c mice intramuscularly immunized with different adjuvants: BQAS, alum, or CQDs [204]. Reproduced with permission.
Copyright © 2020, American Chemical Society
Fig. 11Schematic illustration of various detection methods for SARS-CoV-2 [219]. Reproduced with permission.
Copyright © 2021 IOP Publishing Limited